Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (9,179,004)	$ (4,611,305)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Stock-based compensation	474,097	559,436
Depreciation	20,606	14,634
Non-cash changes in fair value of debt	962,400
Debt issuance costs recognized as expense	1,168,065
Non-cash interest expense		1,378
Changes in operating assets and liabilities
Collaboration receivable	5,000,000	(10,000,000)
Prepaid expenses	(430,787)	(2,386)
Other current assets	8,455,326	(9,825,314)
Accounts payable	613,919	(1,243,184)
Accrued expenses	3,707,133	(1,554,676)
Deferred collaboration funding	(5,371,546)	19,813,897
Other current liabilities	(8,433,464)	9,852,524
Net cash (used in) provided by operating activities	(3,013,255)	3,005,004
Cash flows from investing activities:
Purchase of property and equipment	(28,930)	(5,322)
Net cash used in investing activities	(28,930)	(5,322)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs		3,139,047
Receipt of funds from Relief secured loans		4,000,000
Proceeds from Bridge Loan, net of warrant allocation and lender fees	6,013,148
Proceeds from Secured Convertible Notes, net of lender fees	5,516,556
Proceeds allocated to SWK Warrant based on valuation	327,031
Payment of debt and convertible debt issuance costs	(724,928)
Net cash provided by financing activities	11,131,807	7,139,047
Net increase in cash and cash equivalents	8,089,622	10,138,729
Cash and cash equivalents, beginning of period	12,710,762	5,761,568
Cash and cash equivalents, end of period	$ 20,800,384	15,900,297
Non-cash financing activities:
Non-cash repayment of secured loan		$ 4,000,000